000			02608cam a2200253 a 4500
001			vtls003213491
003			MY-SjTCS
005			20200226114526.0
008			110218s2007 njua b 001 0 eng
020			_a9780471752158 (hbk.)
020			_a0471752150 (hbk.)
039		9	_a201103141636 _bwilmina _c201103091409 _dmasrina _c201102181401 _dVLOAD _y201011291635 _zmuhammad_fadzli
082	0	4	_a615.19 _bART 2007
245	0	4	_aThe art of drug synthesis / _cedited by Douglas S. Johnson, Jie Jack Li.
260			_aHoboken, N.J. : _bWiley-Interscience, _cc2007.
300			_axv, 276 p. : _bill. ; _c26 cm.
504			_aIncludes bibliographical references and index.
505	0		_aThe role of medicinal chemistry in drug discovery / John A. Lowe III -- Process research: how much? how soon? / Neal G. Anderson -- Aromatase inhibitors for breast cancer : exemestane (Aromasin), anastrozole (Arimidex), and letrozole (Femara) / Jie Jack Li -- Quinolone antibiotics : levofloxacin (Levaquin), moxifloxacin (Avelox), gemifloxacin (Factive), and garenoxacin (T-3811) / Chris Limberakis -- Triazole antifungals : itraconazole (Sporanox), fluconazole (Diflucan), voriconazole (Vfend), and fosfluconazole (Prodif) / Andrew S. Bell -- Non-nucleoside HIV reverse transcriptase inhibitors / Arthur Harms -- Neuraminidase inhibitors for influenza : oseltamivir phosphate (Tamiflu) and zanamivir (Relenza) / Douglas S. Johnson and Jie Jack Li -- Peroxisome proliferator-activated receptor (PPAR) agonists for type 2 diabetes / Jin Li -- Angiotensin AT1 antagonists for hypertension / Larry Yet -- Leading ACE inhibitors for hypertension / Victor J. Cee and Edward J. Olhava -- Dihydropyridine calcium channel blockers for hypertension / Daniel P. Christen -- Second-generation HMG-CoA reductase inhibitors / Jeffrey A. Pfefferkorn -- Cholesterol absorption inhibitors: ezetimibe (zetia) / Stuart B. Rosenblum -- Dual selective serotonin and norepinephrine reuptake inhibitors (SSNRIs) for depression / Marta Piñeiro-Núñez -- GABA receptor agonists for insomnia : zolpidem (Ambien), zaleplon (Sonata), eszopiclone (Estorra, Lunesta), and indiplon / Peter R. Guzzo -- Ligands: neurontin (Gabapentin) and lyrica (Pregabalin) / Po-Wai Yuen -- Approved treatments for attention deficit hyperactivity disorder : amphetamine (Adderall), methylphenidate (Ritalin), and atomoxetine (Straterra) / David L. Gray.
650		0	_aDrugs _xDesign. _921816
650		0	_aPharmaceutical chemistry. _921185
700	1		_aJohnson, Douglas S. _q(Douglas Scott), _d1968- _948894
700	1		_aLi, Jie Jack. _921503
920			_aSMN : 156177
999			_c133926 _d133926